arrow
D

Daniel Engelman

University of Melbourne
H指数:32
被引数:4,010

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of one and two doses of ivermectin mass drug administration in reducing the prevalence and intensity of soiltransmitted helminth (STH) infections in Western Province, Solomon Islands: a cluster-randomised, before-after analysis

在所罗门群岛西部省,一剂和两剂伊维菌素大规模药物管理对降低社区传播的蠕虫 (STH) 感染的患病率和强度的有效性: 聚类随机,前后分析

2024-01-014
OAAI
Refining Risk Stratification Among Children With Latent Rheumatic Heart Disease
2023-06-134
PRE
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipalities in Timor-Leste: a before-after assessment

伊维菌素、枸橼酸乙胺嗪和阿苯达唑大规模药物管理对东帝汶三个城市学龄儿童疥疮和土壤传播蠕虫流行的影响: 前后评估

2023-06-019
OAAI
One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial
2023-03-172
OAAI
A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? (vol 15, e0009144, 2021)

体重不足15公斤的儿童使用伊维菌素的系统回顾和个体患者数据荟萃分析: 是时候重新考虑当前的禁忌症了吗?(第15卷,e0009144,2021)

2023-01-063
OAAI
Prevention of bacterial complications of scabies using mass drug administration: A population-based, before-after trial in Fiji, 2018-2020
2022-05-0110
OAAI
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease

潜伏性风湿性心脏病的二级抗生素预防

2022-01-2095
OA